Guselkumab and risankizumab for psoriasis have the highest rates of drug survival among biologics measured and a comparable safety profile.

Rates of Raynaud phenomenon medication initiation are low among patients with SSc in the United States, with less than one-third receiving consistent treatment.

Between the years 2010 and 2019, the percentage of publicly insured children with a mental health or neurodevelopmental diagnosis increased.

Among pediatric patients with AD, dermatologists more frequently prescribe treatments while allergists order more diagnostic testing.

The Trump administration's denial of visas for certain countries prevents medical residents from filling critical positions in US hospitals.

Medicated shampoo containing selenium sulfide and salicylic acid is effective in patients with seborrheic dermatitis, particularly among men.

While some topical herbal therapies may provide benefit for patients with AD, systemic herbal therapies do not provide significant benefit.

Pain is common among patients with IIMs and is linked to worse physical function, increased fatigue, and reduced quality of life.

Several medical organizations are suing the HHS and Secretary Robert F. Kennedy Jr based on recent actions resulting in significant changes in vaccine policy in the US.

Adalimumab and other biologic therapies for hidradenitis suppurativa show similar efficacy for treating the disease.

The CDC already recommends the RSV shot for all adults 75 and older and for people 60 and older who have health conditions that increase their risk of severe RSV. It also recommends the shot during ...

There have been more than 1270 cases of measles confirmed in the US in 2025, though many cases have likely gone unreported.